1.Hydroxytyrosol mediates S100A9/TLR4/NF-κB signaling pathway to regulate macrophage polarization and improve wound healing in burn rats
Futai CHEN ; Yongsuo LIU ; Yuanzheng CHEN
Immunological Journal 2025;41(2):86-90,96
Objective To explore the effects of hydroxytyrosol-mediated macrophage polarization on burn wound healing in rats.Methods SD rats were randomly divided into burn group,hydroxytyrosol group,hydroxytyrosol+ov-NC group and hydroxytyrosol+ov-S100A9 group,with 10 rats in each group.Burn model was established by metal weight burn method.Wound healing rate was calculated;HE staining was used to observe the pathological changes of wound skin tissue in rats;immunofluorescence was used to detect the ratios of M1 and M2 macrophages in the wound skin of rats;ELISA was used to detect the levels of macrophage inflammatory factors in the wound skin of rats;Western blot was used to detect the expression of S100A9/TLR4/NF-κB signal pathway in wound skin of rats.Results Compared with the burn group,hydroxytyrosol group and hydroxytyrosol+ov-NC group demonstrated higher wound healing ability and alleviated pathological damage,lower levels of M1 type macrophages and related factors,higher levels of M2 type macrophages and related factors,and lower expression of S100A9,TLR4 and p-NF-κB p65 proteins.Compared with hydroxytyrosol group and hydroxytyrosol+ov-NC group,S100A9 overexpression reduced the wound healing ability and aggravated the pathological damage,increased M1 type macrophages and related factors,decreased M2 type macrophages and related factors,and increased the expression of S100A9,TLR4 and p-NF-κB p65 proteins in hydroxytyrosol+ov-S100A9 group.Conclusion Hydroxytyrosol promotes wound healing in burn rats by down-regulating S100A9,and its mechanism may be related to inhibiting the activation of TLR4/NF-κB signaling pathway and improving the imbalance of M1/M2 macrophages.
2.Hydroxytyrosol mediates S100A9/TLR4/NF-κB signaling pathway to regulate macrophage polarization and improve wound healing in burn rats
Futai CHEN ; Yongsuo LIU ; Yuanzheng CHEN
Immunological Journal 2025;41(2):86-90,96
Objective To explore the effects of hydroxytyrosol-mediated macrophage polarization on burn wound healing in rats.Methods SD rats were randomly divided into burn group,hydroxytyrosol group,hydroxytyrosol+ov-NC group and hydroxytyrosol+ov-S100A9 group,with 10 rats in each group.Burn model was established by metal weight burn method.Wound healing rate was calculated;HE staining was used to observe the pathological changes of wound skin tissue in rats;immunofluorescence was used to detect the ratios of M1 and M2 macrophages in the wound skin of rats;ELISA was used to detect the levels of macrophage inflammatory factors in the wound skin of rats;Western blot was used to detect the expression of S100A9/TLR4/NF-κB signal pathway in wound skin of rats.Results Compared with the burn group,hydroxytyrosol group and hydroxytyrosol+ov-NC group demonstrated higher wound healing ability and alleviated pathological damage,lower levels of M1 type macrophages and related factors,higher levels of M2 type macrophages and related factors,and lower expression of S100A9,TLR4 and p-NF-κB p65 proteins.Compared with hydroxytyrosol group and hydroxytyrosol+ov-NC group,S100A9 overexpression reduced the wound healing ability and aggravated the pathological damage,increased M1 type macrophages and related factors,decreased M2 type macrophages and related factors,and increased the expression of S100A9,TLR4 and p-NF-κB p65 proteins in hydroxytyrosol+ov-S100A9 group.Conclusion Hydroxytyrosol promotes wound healing in burn rats by down-regulating S100A9,and its mechanism may be related to inhibiting the activation of TLR4/NF-κB signaling pathway and improving the imbalance of M1/M2 macrophages.
3.Multicenter evaluation of the diagnostic efficacy of jaundice color card for neonatal hyperbilirubinemia
Guochang XUE ; Huali ZHANG ; Xuexing DING ; Fu XIONG ; Yanhong LIU ; Hui PENG ; Changlin WANG ; Yi ZHAO ; Huili YAN ; Mingxing REN ; Chaoying MA ; Hanming LU ; Yanli LI ; Ruifeng MENG ; Lingjun XIE ; Na CHEN ; Xiufang CHENG ; Jiaojiao WANG ; Xiaohong XIN ; Ruifen WANG ; Qi JIANG ; Yong ZHANG ; Guijuan LIANG ; Yuanzheng LI ; Jianing KANG ; Huimin ZHANG ; Yinying ZHANG ; Yuan YUAN ; Yawen LI ; Yinglin SU ; Junping LIU ; Shengjie DUAN ; Qingsheng LIU ; Jing WEI
Chinese Journal of Pediatrics 2024;62(6):535-541
Objective:To evaluate the diagnostic efficacy and practicality of the Jaundice color card (JCard) as a screening tool for neonatal jaundice.Methods:Following the standards for reporting of diagnostic accuracy studies (STARD) statement, a multicenter prospective study was conducted in 9 hospitals in China from October 2019 to September 2021. A total of 845 newborns who were admitted to the hospital or outpatient department for liver function testing due to their own diseases. The inclusion criteria were a gestational age of ≥35 weeks, a birth weight of ≥2 000 g, and an age of ≤28 days. The neonate′s parents used the JCard to measure jaundice at the neonate′s cheek. Within 2 hours of the JCard measurement, transcutaneous bilirubin (TcB) was measured with a JH20-1B device and total serum bilirubin (TSB) was detected. The Pearson′s correlation analysis, Bland-Altman plots and the receiver operating characteristic (ROC) curve were used for statistic analysis.Results:Out of the 854 newborns, 445 were male and 409 were female; 46 were born at 35-36 weeks of gestational age and 808 were born at ≥37 weeks of gestational age. Additionally, 432 cases were aged 0-3 days, 236 cases were aged 4-7 days, and 186 cases were aged 8-28 days. The TSB level was (227.4±89.6) μmol/L, with a range of 23.7-717.0 μmol/L. The JCard level was (221.4±77.0) μmol/L and the TcB level was (252.5±76.0) μmol/L. Both the JCard and TcB values showed good correlation ( r=0.77 and 0.80, respectively) and agreements (96.0% (820/854) and 95.2% (813/854) of samples fell within the 95% limits of agreement, respectively) with TSB. The JCard value of 12 had a sensitivity of 0.93 and specificity of 0.75 for identifying a TSB ≥205.2?μmol/L, and a sensitivity of 1.00 and specificity of 0.35 for identifying a TSB ≥342.0?μmol/L. The TcB value of 205.2?μmol/L had a sensitivity of 0.97 and specificity of 0.60 for identifying TSB levels of 205.2 μmol/L, and a sensitivity of 1.00 and specificity of 0.26 for identifying TSB levels of 342.0 μmol/L. The areas under the ROC curve (AUC) of JCard for identifying TSB levels of 153.9, 205.2, 256.5, and 342.0 μmol/L were 0.96, 0.92, 0.83, and 0.83, respectively. The AUC of TcB were 0.94, 0.91, 0.86, and 0.87, respectively. There were both no significant differences between the AUC of JCard and TcB in identifying TSB levels of 153.9 and 205.2 μmol/L (both P>0.05). However, the AUC of JCard were both lower than those of TcB in identifying TSB levels of 256.5 and 342.0 μmol/L (both P<0.05). Conclusions:JCard can be used to classify different levels of bilirubin, but its diagnostic efficacy decreases with increasing bilirubin levels. When TSB level are ≤205.2 μmol/L, its diagnostic efficacy is equivalent to that of the JH20-1B. To prevent the misdiagnosis of severe jaundice, it is recommended that parents use a low JCard score, such as 12, to identify severe hyperbilirubinemia (TSB ≥342.0 μmol/L).
4.Predictors of Difficult Laryngeal Exposure in Suspension Laryngoscopy: A Systematic Review and Meta-Analysis
Mengshu WANG ; Yong LIU ; Yuanzheng QIU ; Huihong CHEN ; Wang LIWEN ; Donghai HUANG ; Xin ZHANG ; Guo LI
Clinical and Experimental Otorhinolaryngology 2024;17(2):177-187
Objectives:
. Considerable research has been focused on independent predictors of difficult laryngeal exposure (DLE) during suspension laryngoscopy. However, previous studies have yielded inconsistent results and conclusions. Consequently, we performed a meta-analysis of the existing literature with the aim of identifying significant parameters for a standardized preoperative DLE prediction system.
Methods:
. We systematically retrieved articles from the PubMed, Embase, Web of Science, China National Knowledge Infrastructure, and Wanfang databases up to October 2022. Data from eligible studies were extracted and analyzed using the R programming language. The effect measures included odds ratios (ORs) with 95% confidence intervals (CIs) for dichotomous variables and mean differences (MDs) with 95% CIs for continuous variables.
Results:
. The search yielded 1,574 studies, of which 18 (involving a total of 2,263 patients) were included. Pooled analysis demonstrated that patients with DLE during microsurgery tended to be male (OR, 1.73; 95% CI, 1.16–2.57); were older (MD, 5.47 years, 95% CI, 2.44–8.51 years); had a higher body mass index (BMI; MD, 1.19 kg/m2; 95% CI, 0.33–2.05 kg/m2); had a greater neck circumference (MD, 2.50 cm; 95% CI, 1.56–3.44 cm); exhibited limited mouth opening (MD, −0.52 cm; 95% CI, −0.88 to −0.15 cm); had limited neck flexibility (MD, −10.05 cm; 95% CI, −14.10 to −6.00 cm); displayed various other anatomical characteristics; and had a high modified Mallampati index (MMI) or test score (OR, 3.37; 95% CI, 2.07–5.48).
Conclusion
. We conducted a comprehensive and systematic analysis of the factors relevant to DLE. Ultimately, we identified sex, age, BMI, neck circumference, MMI, inter-incisor gap, hyomental distance, thyromental distance, sternomental distance, and flexion-extension angle as factors highly correlated with DLE.
5.Research progress of botulinum toxin type A in the prevention and treatment of hypertrophic scar
Qingwen YANG ; Liang LI ; Yuanzheng CHEN
Chinese Journal of Plastic Surgery 2023;39(3):242-246
Hypertrophic scar is the most common scar in clinic. Due to its high incidence, high rate of relapse and difficulty of complete removal, it has always been a big problem in burn and plastic surgery. In recent years, some scholars have found that botulinum toxin type A(BTX-A) can inhibit scar hyperplasia by reducing the tension around the wound, inhibiting the proliferation of fibroblasts, promoting their apoptosis, promoting the degradation of collagen fibers, reducing wound angiogenesis, reducing inflammation around the wound and other mechanisms. BTX-A has fewer adverse reactions and high safety. Additionally, its effect combined with triamcinolone acetonide and laser in treating scars is significant. Therefore, it has been widely used in the treatment of hypertrophic scars. In this paper, the research progress of BTX-A in the prevention and treatment of hypertrophic scar were reviewed in order to provide new ideas for the treatment of hypertrophic scar.
6.Botulinum toxin type A for the prevention and treatment of hypertrophic scars: updated review
Qingwen YANG ; Liang LI ; Yuanzheng CHEN
Chinese Journal of Plastic Surgery 2023;39(6):685-689
Hypertrophic scar is the most common scar in the clinic. Due to its high incidence, high rate of recurrence, and difficulty of complete removal, it has always been a major problem in the department of burn and plastic surgery. In recent years, some scholars have found that botulinum toxin type A(BTX-A) can inhibit scar hyperplasia by reducing the tension around the wound, inhibiting the proliferation of fibroblasts, promoting their apoptosis, promoting the degradation of collagen fibers, reducing wound angiogenesis, reducing inflammation around the wound and other mechanisms. BTX-A has fewer adverse reactions and high safety. Additionally, its effect combined with triamcinolone acetonide and laser in treating scars is significant. Therefore, it has been widely used in the treatment of hypertrophic scars. In this paper, the research progress of BTX-A in the prevention and treatment of hypertrophic scar was reviewed in order to provide new ideas for the treatment of hypertrophic scar.
7.Research progress of botulinum toxin type A in the prevention and treatment of hypertrophic scar
Qingwen YANG ; Liang LI ; Yuanzheng CHEN
Chinese Journal of Plastic Surgery 2023;39(3):242-246
Hypertrophic scar is the most common scar in clinic. Due to its high incidence, high rate of relapse and difficulty of complete removal, it has always been a big problem in burn and plastic surgery. In recent years, some scholars have found that botulinum toxin type A(BTX-A) can inhibit scar hyperplasia by reducing the tension around the wound, inhibiting the proliferation of fibroblasts, promoting their apoptosis, promoting the degradation of collagen fibers, reducing wound angiogenesis, reducing inflammation around the wound and other mechanisms. BTX-A has fewer adverse reactions and high safety. Additionally, its effect combined with triamcinolone acetonide and laser in treating scars is significant. Therefore, it has been widely used in the treatment of hypertrophic scars. In this paper, the research progress of BTX-A in the prevention and treatment of hypertrophic scar were reviewed in order to provide new ideas for the treatment of hypertrophic scar.
8.Botulinum toxin type A for the prevention and treatment of hypertrophic scars: updated review
Qingwen YANG ; Liang LI ; Yuanzheng CHEN
Chinese Journal of Plastic Surgery 2023;39(6):685-689
Hypertrophic scar is the most common scar in the clinic. Due to its high incidence, high rate of recurrence, and difficulty of complete removal, it has always been a major problem in the department of burn and plastic surgery. In recent years, some scholars have found that botulinum toxin type A(BTX-A) can inhibit scar hyperplasia by reducing the tension around the wound, inhibiting the proliferation of fibroblasts, promoting their apoptosis, promoting the degradation of collagen fibers, reducing wound angiogenesis, reducing inflammation around the wound and other mechanisms. BTX-A has fewer adverse reactions and high safety. Additionally, its effect combined with triamcinolone acetonide and laser in treating scars is significant. Therefore, it has been widely used in the treatment of hypertrophic scars. In this paper, the research progress of BTX-A in the prevention and treatment of hypertrophic scar was reviewed in order to provide new ideas for the treatment of hypertrophic scar.
9.Thirty Cases of Front-orbital Fibrous Dysplasia: Intraoperative Optic Canal Localization with Three-bits Method and Outcomes Evaluation
Bo BU ; Lifeng CHEN ; Chong LI ; Ruyuan ZHU ; Yuanzheng ZHANG ; Xinguang YU ; Jianning ZHANG
Cancer Research on Prevention and Treatment 2022;49(6):535-540
Objective To investigate the indications of optic canal decompression in the patients with front-orbital fibrous dysplasia and the methods of intraoperative optic canal localization and decompression. Methods We collected 30 cases of fibrous dysplasia. All patients had sufficient images assessment. Patients with symptoms underwent surgery, including front-orbital cranioplasty and optic canal decompression. The frontotemporal epidural approaches were used. If there was a proptosis, the approach was extended with the removal of superior orbital ridge. Six patients undertook intraoperative CT and MRI fusion navigation, assisting in confirming the trunk, orbital and cranial orifice of optic nerve. During the operation, the optic canals were decompressed by three-bits method, to confirm the position of optic nerve. Results There were 30 cases of optic canal decompression and one case of vision loss. The visual acuity and vision field of the remaining patients improved to varying degrees. The proptosis disappeared or alleviated after the operation. Thirteen cases were reconstructed with normal internal plate, five cases with titanium plate, nine cases without reconstruction, and two cases were paved with proliferative broken bone on the orbital top; one case recurred with exophthalmos again after five years, but the visual acuity did not decline. Conclusion For the patients with front-orbital fibrous dysplasia, active surgical treatment should be taken, optic canal decompression should be chosen for diminution of vision, craniofacial anaplasty and orbital decompression should be performed in patients with facial deformity. The epidural approach is a good option to locate the optic nerve from the orbital orifice or cranial orifice. Combined with the three-bits method, we can achieve safe and meticulous optic nerve decompression.
10.Comparison of blood glucose-lowering function of transplant islets between subcutaneous adipose tissues of inguinal region and renal capsule in mice
Yuanzheng PENG ; Zhicheng ZOU ; Jiao CHEN ; Ying LU ; Hancheng ZHANG ; Zhiming CAI ; Lisha MOU
Organ Transplantation 2019;10(6):684-
Objective To compare the effect of transplant islets between the subcutaneous inguinal white adipose tissues and renal capsule in the treatment of type 1 diabetes mellitus in mouse models. Methods The mice with type 1 diabetes mellitus undergoing islet transplantation were divided into the white adipose group (

Result Analysis
Print
Save
E-mail